doi: 10.1023/a:1024121017841
By activating both GLP-1 and GIP receptors, tirzepatide heightens feelings of fullness, diminishes food cravings, and optimizes insulin sensitivity
Compounding pharmacy quality and compliance practices vary - confirming pharmacy licensing for your specific prescription is reasonable
Who Is at Higher Risk for Mood Changes on Tirzepatide and GLP-1 Therapy People with a history of major depressive disorder, bipolar disorder, prior suicidal ideation, or unstable psychiatric conditions face a higher risk for psychiatric adverse events on any weight loss drug
3,4 Wegovy is available through specialist NHS weight-management services for people with a BMI of 35 or above, or 32.5 or above for some ethnic groups, who also have a weight-related health problem
Each shipment carries a tracking number, requires a signature at delivery, and is packed with thermal protection sized to the destination, the season, and the forecast route conditions on the day of dispatch